Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Dynamic treatment model to examine the association between phenotypic drug resistance and duration of HIV viral suppression.

Bulletin of mathematical biology - 1 Nov 2005

Snedecor Sonya J

Abstract excerpt

Recent advances in the chemotherapy of HIV infection have been successful in delaying the progression of disease in many patients and are responsible for the decline in HIV-related deaths in the United States. Yet, there are many patients who fail to maintain suppressed viral loads on treatment. Means to extend the utility of currently available drugs include developing improved ways to assess the therapeutic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents
Share to Drug Resistance, Viral
Share to HIV

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to HIV Infections

Share to Models, Biological

Share to Mutation

Share to Viral Load

Source

Identifiers

PMID: 16005505
DOI: 10.1016/j.bulm.2005.02.004

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Dynamic treatment model to examine the association between phenotypic drug resistance and duration of HIV viral suppression.PMID 16005505Read ↗

Understanding patterns of HIV multi-drug resistance through models of temporal and spatial drug heterogeneitySemantic proximity Read ↗

Understanding patterns of HIV multi-drug resistance through models of temporal and spatial drug heterogeneity.Semantic proximity Read ↗

Antiretroviral dynamics determines HIV evolution and predicts therapy outcome.Semantic proximity Read ↗

Computational models of HIV-1 resistance to gene therapy elucidate therapy design principles.Semantic proximity Read ↗

Mechanism of HIV antiretroviral drugs progress toward drug resistance.Semantic proximity Read ↗

Mathematical approaches in the study of viral kinetics and drug resistance in HIV-1 infection.Semantic proximity Read ↗

Drug-resistance mutations number and K70R or T215Y/F substitutions predict treatment resumption during guided treatment interruptions.Semantic proximity Read ↗

Improved prediction of response to antiretroviral combination therapy using the genetic barrier to drug resistance.Semantic proximity Read ↗

A phylogenetic and Markov model approach for the reconstruction of mutational pathways of drug resistance.Semantic proximity Read ↗

Modeling HIV dynamics and antiviral response with consideration of time-varying drug exposures, adherence and phenotypic sensitivity.Semantic proximity Read ↗

A multi-variant, viral dynamic model of genotype 1 HCV to assess the in vivo evolution of protease-inhibitor resistant variants.Semantic proximity Read ↗

Dynamic multidrug therapies for HIV: a control theoretic approach.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.